top of page

Fact Sheet I


  • MDMA is currently in Phase III FDA trials for treating PTSD

  • Standard treatment = 9 sessions of psychotherapy, 3 of which include the use of MDMA

  • Control group only gets psychotherapy

  • Two months after the interventions, 23% of control group no longer have PTSD vs. 56% in the MDMA group

  • Long-term follow-up (one year after treatment ends), 67% of participants no longer have PTSD, compared with less than 25% in the control group (therapy only)

Modern Work Space
Fact Sheet I: Projects
bottom of page